Developmental outcomes of children exposed to antidepressants in pregnancy

References

• Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005; 162:79–91.
   PubMed Web of Science ®Google Scholar
• Austin MP, Kildea S, Sullivan E. Maternal mortality and psychiatric morbidity in the perinatal period: challenges and opportunities for prevention in the Australian setting. Med J Aust 2007; 186: 364–367.
   PubMed Web of Science ®Google Scholar
• Murray L, Fiori-Cowley A, Hooper R, Cooper P. The impact of postnatal depression and associated adversity on early mother– infant interactions and later infant outcome. Child Dev 1996; 67:2512–2526.
   PubMed Web of Science ®Google Scholar
• Deave T, Heron J, Evans J, Emond A. The impact of maternal depressionin pregnancy on early child development. Br J Obstet Gynecol 2008; 115:1043–1051.
   Google Scholar
• Murray L, Sinclair D, Cooper P, Ducournau P, Turner P, Stein A. The socioemotional development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry 1999; 40:1259–1271.
   PubMed Web of Science ®Google Scholar
• Murray L, Cooper PJ. Postpartum depression and child development. Psychol Med 1997; 27:253–260.
   PubMed Web of Science ®Google Scholar
• Nulman I, Rovet J, Stewart DE . Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002; 159:1889–1895.
   PubMed Web of Science ®Google Scholar
• Hay DF, Pawlby S, Waters CS, Sharp D. Antepartum and postpartum exposure to maternal depression: different effects on different adolescent outcomes. J Child Psychol Psychiatry 2008; 49:1079–1088.
   PubMed Web of Science ®Google Scholar
• O'Connor TG, Ben-Shlomo Y, Heron J, Golding J, Adams D, Glover V. Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol Psychiatry 2005; 58:211–217.
   PubMed Web of Science ®Google Scholar
• Brennan PA, Pargas R, Walker EF, Green P, Newport DJ, Stowe Z. Maternal depression and infant cortisol: influences of timing, comorbidity and treatment. J Child Psychol Psychiatry 2008; 49:1099–1107.
   PubMed Web of Science ®Google Scholar
• Cohen LS, Nonacs RM, Bailey JW . Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Arch Women's Ment Health 2004; 7:217–221.
   PubMedGoogle Scholar
• Weissman M, Pilowsky D, Wickramaratne P . Remissions in maternal depression and child psychopathology. A Star*D-Child Report. JAMA 2006; 295:1389–1398.
   PubMed Web of Science ®Google Scholar
• Andrade SE, Raebel MA, Brown J . Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008; 198:194 e1–5.
   PubMedGoogle Scholar
• Cooper WO, Willy ME, Pont SJ, Ray WA. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007; 196:544 e1–5.
   PubMedGoogle Scholar
• Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006; 63:898–906.
   PubMed Web of Science ®Google Scholar
• Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. Am J Psychiatry 2003; 160:993–996.
   PubMed Web of Science ®Google Scholar
• Nulman I, Koren G. The safety of fluoxetine during pregnancy and lactation. Teratology 1996; 53:304–308.
   Google Scholar
• Nulman I, Rovet J, Stewart DE . Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336:258–262.
   PubMed Web of Science ®Google Scholar
• Casper RC, Fleisher BE, Lee-Ancajas JC . Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003;142:402–408.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988; 8:77–100.
   Web of Science ®Google Scholar
• Katz R, Katz J, Shaw BF. Beck Depression Inventory and Hopelessness Scale. Maruish ME, The use of psychological testing for treatment planning and outcomes assessment 2nd. Mahwah, New Jersey: Lawrence Erlbaum, 1999.
   Google Scholar
• Bayley N. The Bayley Scales of Infant Development, third. Mahwah, New Jersey: Pearson, 2005.
   Google Scholar
• Hersen M. Comprehensive handbook of psychological assessment. Hoboken, New Jersey: Wiley, 2004.
   Google Scholar
• Galbally ML, Lewis AJ, Lum J, Buist AE. Serotonin discontinuation syndrome following in utero exposure to anti-depressant medication: a prospective controlled study. Aust N Z J Psychiatry 2009; 43:846–854.
   PubMed Web of Science ®Google Scholar
• Lewis AJ, Galbally M, Opie G, Buist A. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication. Aust N Z J Psychiatry 2010; 44:482–487.
   PubMed Web of Science ®Google Scholar
• Saper CB. Brain stem modulation of sensation, movement, and conciousness. Kandel ER, Schwartz JH, Jessell TM, Principles of neural science, fourth. New York: McGraw-Hill, 2000:889–908.
   Google Scholar
• Allman J. Evolving brains. New York: Scientific American Library, 2000.
   Google Scholar
• Whitaker-Azmitia PM, Druse M, Walker P, Lauder JM. Serotonin as a developmental signal. Behav Brain Res 1996; 73:19–29.
   PubMed Web of Science ®Google Scholar
• Vartazarmian R, Malik S, Baker GB, Boksa P. Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring. Psychopharmacology (Berl) 2005; 178:328–338.
   PubMedGoogle Scholar
• Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. Early-life blockade of the 5-HT transporter alters emotional behaviour in adult mice. Science 2004; 306:879–881.
   PubMed Web of Science ®Google Scholar
• Maciag D, Simpson KL, Coppinger D . Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 2006; 31:47–57.
   PubMed Web of Science ®Google Scholar
• Norrholm SD, Ouimet CC. Chronic fluoxetine administration to juvenile rats prevents age-associated dendritic spine formation in hippocampus. Brain Res 2000; 883:205–215.
   PubMedGoogle Scholar
• Gentile S, Galbally M. Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review. J Affect Disord 2011; 128:1–9.
   PubMed Web of Science ®Google Scholar
• Mortensen JT, Olsen J, Larsen H, Bendsen J, Obel C, Sorensen HT. Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics. Eur J Epidemiol 2003; 18:769–771.
   PubMed Web of Science ®Google Scholar
• Strauss E, Sherman E, Spreen O. A compendium of neuropsychological tests: administration, norms and commentary, third. Oxford: Oxford University Press, 2006.
   Google Scholar
• McGrath E, Wypij D, Rappaport LA, Newburger JW, Bellinger DC. Prediction of IQ and achievement at age 8 years from neurodevelopmental status at age 1 year in children with D-transposition of the great arteries. Pediatrics 2004; 114:e572–576.
   PubMed Web of Science ®Google Scholar
• Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008; 359:61–73.
   PubMed Web of Science ®Google Scholar
• Galbally M, Lewis A, Snellen M, Paul C, Szego K, Trauer T. Mother–infant psychotherapy and perinatal psychiatry: current clinical practice and future directions. Australas Psychiatry 2006; 14:384–389.
   PubMedGoogle Scholar